Condition

Acute Lymphoblastic Leukemia (1)

Acute Myelogenous Leukemia (1)

Graft Survival (1)

HLA-mismatched Bone Marrow Transplantation (1)

Lymphoma (1)

Myeloablative Conditioning (1)

Myelodysplastic Syndromes (1)

Transplantation, Bone Marrow (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Bellicum Pharmaceuticals (1)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

Collaborator

Study Documents

Intervention Type

drug (2)

biological (1)

other (1)

procedure (1)

radiation (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

haplotransplantation

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting

Acute Lymphoblastic Leukemia
+3 more

BPX-501 dose 1
+5 more

Atlanta, Georgia
+7 more

Jul 10, 2022

Myeloablative Conditioning, HLA-mismatched Bone Marrow Transplantation, Graft Survival Trial in Canada, United States (drug,

Completed

Has Results

Myeloablative Conditioning
+3 more

Cyclophosphamide
+5 more

Aurora, Colorado
+8 more

Nov 23, 2021